Physician profile
Srikanth Krishnan
NPI 1649634957
$5,352.91
in general payments reported to CMS, 2019-2025
9 companies · $1,378 in 2025
The $1,378 reported for 2025 was more than what 77% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $50.00 · 2022: $16.75 · 2023: $367 · 2024: $3,541 · 2025: $1,378.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,000 · Food and Beverage: $1,286.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,000.00 |
| Food and Beverage | $1,286.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $4,816.46 | 2021-2025 | |
| Abbott Laboratories | $140.92 | 2022-2023 | Mitraclip |
| Pfizer INC. | $111.42 | 2023 | |
| Edwards Lifesciences Corporation | $96.94 | 2024-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Pascal |
| Lexicon Pharmaceuticals, INC. | $56.11 | 2023 | Inpefa |
| Cleerly, INC. | $56.01 | 2024 | Cleerly Labs, Cleerly Ischemia |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $26.35 | 2023 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.00 | 2023 | Jardiance |
| Kiniksa Pharmaceuticals, LTD. | $22.70 | 2023 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Srikanth Krishnan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.